Performance specifications for sodium should not be based on biological variation.

Area of Science:

• Clinical Laboratory Science
• Analytical Chemistry
• Medical Diagnostics

Background:

• Accurate laboratory testing is crucial for clinical decision-making.
• Sigma metrics and total permissible error are key performance indicators in clinical laboratories.
• Conventional biological variation (BV) models for setting performance specifications have limitations.

Purpose of the Study:

• To critically evaluate current methods for establishing analytical performance specifications.
• To assess the suitability of biological variation (BV) based models for analytes like sodium.
• To explore alternative approaches, including measurement uncertainty models.

Main Methods:

• Review of existing methodologies for performance specification in clinical laboratories.
• Analysis of sodium concentration measurements in plasma or serum as a case study.
• Comparison of biological variation (BV) based models with measurement uncertainty models.

Main Results:

• Sodium, despite high measurement accuracy, does not meet conventional BV-based performance specifications.
• Current performance specifications based on BV may be inappropriate for tightly regulated analytes.
• Defining analytical quality limits remains a challenge for both BV and measurement uncertainty models.

Conclusions:

• The reliance on biological variation (BV) for setting quality criteria for sodium is questionable.
• Alternative models, such as measurement uncertainty, warrant further investigation for performance specification.
• Revising quality criteria for homeostatically controlled analytes is necessary for accurate clinical laboratory performance evaluation.